Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin - 19 Jan 2017

Trebbien Ramona, Pedersen Svend Stenvang, Vorborg Kristine, Franck Kristina Træholt, Fischer Thea Kølsen

Abstract excerpt

Antiviral treatment of immunocompromised patients with prolonged influenza virus infection can lead to multidrug resistance. This study reveals the selection of antiviral resistance mutations in influenza A(H1N1)pdm09 virus in an immunocompromised patient during a 6-month period. The patient was treated with two courses of oseltamivir (5 days and 2 months, respectively), with the first course starting at symptom...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Denmark
Share to Immunocompromised Host

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Influenza A Virus, H1N1 Subtype

Share to Influenza, Human

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Neuraminidase

Share to Oseltamivir

Share to Zanamivir

Source

Open in PubMed Open full text

Identifiers

PMID: 28128091
DOI: 10.2807/1560-7917.ES.2017.22.3.30445
PMCID: PMC5322288

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.PMID 28128091Read ↗

Molecular pathway of influenza pan-neuraminidase inhibitors resistance in an immunocompromised patientSemantic proximity Read ↗

Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugsSemantic proximity Read ↗

Neuraminidase inhibitor resistance in influenza: a clinical perspectiveSemantic proximity Read ↗

Detection and management of antiviral resistance for influenza virusesSemantic proximity Read ↗

Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.Semantic proximity Read ↗

Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceSemantic proximity Read ↗

Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.Semantic proximity Read ↗

Investigating the Molecular Basis of Antiviral Resistance in the Perspective of Influenza A VirusSemantic proximity Read ↗

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of KoreaSemantic proximity Read ↗

Primarily oseltamivir-resistant influenza A (H1N1pdm09) virus evolving into a multidrug-resistant virus carrying H275Y and I223R neuraminidase substitutions.Semantic proximity Read ↗

Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea.Semantic proximity Read ↗

Recovery of a Multidrug‐Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with OseltamivirSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.